Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Man Study to Evaluate the Safety and Efficacy of Disposable Intravascular Ultrasound Ablation Catheters and Ultrasound Ablation Instrument in the Treatment of Essential Hypertension

NCT05795829 is registered in ClinicalTrials.gov with Lepu Medical Technology (Beijing) Co., Ltd. as lead sponsor.

NCT NCT05795829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05795829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Man Study to Evaluate the Safety and Efficacy of Disposable Intravascular Ultrasound Ablation Catheters and Ultrasound Ablation Instrument in the Treatment of Essential Hypertension
Lead sponsor
Lepu Medical Technology (Beijing) Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
January 16, 2023
Completion date
February 29, 2024
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uncontrolled essential hypertension